OLIG3
Basic information
Region (hg38): 6:137492199-137494394
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OLIG3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 2 | 0 |
Variants in OLIG3
This is a list of pathogenic ClinVar variants found in the OLIG3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-137493398-G-T | not specified | Uncertain significance (Nov 07, 2022) | ||
6-137493422-G-A | not specified | Uncertain significance (Mar 28, 2023) | ||
6-137493483-C-G | not specified | Uncertain significance (Jun 16, 2024) | ||
6-137493530-G-C | not specified | Uncertain significance (Dec 19, 2022) | ||
6-137493570-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
6-137493583-T-C | Likely benign (May 01, 2022) | |||
6-137493624-G-T | not specified | Uncertain significance (Dec 07, 2021) | ||
6-137493654-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
6-137493689-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
6-137493705-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
6-137493716-T-C | not specified | Uncertain significance (Dec 22, 2023) | ||
6-137493784-G-A | Likely benign (Jul 01, 2022) | |||
6-137493812-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
6-137493963-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
6-137494006-G-C | not specified | Uncertain significance (May 18, 2022) | ||
6-137494018-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
6-137494030-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
6-137494032-T-C | not specified | Uncertain significance (Oct 07, 2022) | ||
6-137494094-T-C | not specified | Uncertain significance (Jun 10, 2024) | ||
6-137494112-A-C | not specified | Uncertain significance (Dec 01, 2022) | ||
6-137494131-A-T | not specified | Uncertain significance (Dec 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OLIG3 | protein_coding | protein_coding | ENST00000367734 | 1 | 2196 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.834 | 0.163 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.248 | 159 | 150 | 1.06 | 0.00000702 | 1743 |
Missense in Polyphen | 45 | 53.984 | 0.83358 | 665 | ||
Synonymous | -0.791 | 78 | 69.6 | 1.12 | 0.00000343 | 578 |
Loss of Function | 2.25 | 0 | 5.91 | 0.00 | 2.56e-7 | 72 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May determine the distinct specification program of class A neurons in the dorsal part of the spinal cord and suppress specification of class B neurons.;
- Pathway
- Neural Crest Differentiation
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 32.94
Haploinsufficiency Scores
- pHI
- 0.531
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.445
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.988
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Olig3
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;spinal cord motor neuron cell fate specification;spinal cord motor neuron migration
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;transcription corepressor activity;protein binding;protein dimerization activity